Jamila Louahed

Efficacy of the MAGE-A3 cancer immunotherapeutic as adjuvant therapy in patients with resected MAGE-A3-positive non-small-cell lung cancer (MAGRIT): a randomised, double-blind, placebo-controlled, phase 3 trial

Johan Vansteenkiste, Byoung Chul Cho, Tõnu Vanakesa et al. · The Lancet Oncology · 2016 · 497 citations · Full text

Medicine, Immunology, Oncology +16

Cloning and Characterization of IL-10-Related T Cell-Derived Inducible Factor (IL-TIF), a Novel Cytokine Structurally Related to IL-10 and Inducible by IL-9

Laure Dumoutier, Jamila Louahed, Jean‐Christophe Renauld · The Journal of Immunology · 2000 · 495 citations · Full text

Life Sciences, Genetics, Immunology +15

Predictive Gene Signature in MAGE-A3 Antigen-Specific Cancer Immunotherapy

Fernando Ulloa‐Montoya, Jamila Louahed, Benjamin Dizier et al. · Journal of Clinical Oncology · 2013 · 475 citations · Full text

Medicine, Immunology, Oncology +17

Interleukin-9 Upregulates Mucus Expression in the Airways

Jamila Louahed, Masao Toda, Jin Jen et al. · American Journal of Respiratory Cell and Molecular Biology · 2000 · 273 citations

Life Sciences, Cell Biology, Immunology +15

Selection of Immunostimulant AS15 for Active Immunization With MAGE-A3 Protein: Results of a Randomized Phase II Study of the European Organisation for Research and Treatment of Cancer Melanoma Group in Metastatic Melanoma

Wim H.J. Kruit, Stefan Suciu, Brigitte Dréno et al. · Journal of Clinical Oncology · 2013 · 222 citations

Life Sciences, Immunology, Oncology +17